Global Respiratory Diagnostics Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027
MarketResearch.biz delivers in-depth insights on the global respiratory diagnostics market in its upcoming report titled, “Global Respiratory Diagnostics Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global respiratory diagnostics market is estimated to register a CAGR of XXX% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global respiratory diagnostics market report has been segmented on the basis of product and service, test type, disease, end user, and region.
Respiratory diseases represent a major cause of morbidity and mortality among all age groups worldwide. Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and the numbers are growing. Five respiratory conditions accounting for a great burden to society are chronic obstructive pulmonary disease, asthma, acute respiratory infections, tuberculosis, and lung cancer. According to Forum of International Respiratory Societies (FIRS), each year 4 million people die from chronic respiratory disease.
Key market driver of global respiratory diagnostics is, increasing prevalence of respiratory diseases. In addition, technological advancement in respiratory diagnostic testing, growth in geriatric population with respiratory disorders, increase in the demand for respiratory devices in private hospitals and clinics, high consumption of tobacco and smoking, urbanization, growing pollution levels, sedentary lifestyle are the factors boosting the growth of global respiratory diagnostics market. However, high price associated diagnosis and testing, strict regulatory requirements and reimbursement concerns hinder the growth of market.
Respiratory diseases are an enormous challenge to life, health and productive human activity. The government are taking various initiative to spread the public awareness and control of the environment regarding prevention and treatment of respiratory diseases. The key players are focusing on new product launches, clinical trials, research and development, through agreements, joint ventures, partnerships, acquisitions, with other players.
The market in North America is estimated to dominate the respiratory diagnostics, rising prevalence of respiratory diseases such as COPD, asthma etc. The market in Asia Pacific is the emerging market for respiratory diagnostics due to improving health care infrastructure and increasing patient awareness regarding availability of diagnostic procedures. The emerging economies of Asia Pacific region, such as China and India are offering huge revenue generation opportunities for the key players in the market.
Segmentation on the basis of product and service:
- Instruments & Devices
- Assays & Reagents
- Software & Services
Segmentation on the basis of test type:
- Mechanical tests
- Imaging tests
- Traditional diagnostic tests
- Molecular diagnostic tests
Segmentation on the basis of disease:
- Chronic obstructive pulmonary disease
- Lung cancer
- Other diseases (including, bronchitis, respiratory infection, pulmonary fibrosis etc.)
Segmentation on the basis of end user:
- Other end users (including blood banks, point-of-care testing, patient self-testing etc.)
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Becton, Dickinson and Company
- Koninklijke Philips N.V
- MGC Diagnostics Corporation
- Medtronic, Inc.
- CAREstream Medical Ltd.
- ResMed Inc.
- Thermo Fisher Scientific Inc.
- GE Healthcare Limited
- Abbott Diagnostics Inc.
- Fisher & Paykel Healthcare, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!